Financial Toxicity

Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

BACKGROUND Cancer and its treatment lead to increased financial distress for patients. To the authors' knowledge, to date, no standardized patient-reported outcome measure has been validated to assess this distress. METHODS Patients with AJCC Stage IV solid tumors receiving chemotherapy for at least 2 months were recruited. Financial toxicity was measured by the COmprehensive Score for financ...

Value and Financial Toxicity of New Cancer Drugs

Low-value practices in oncology contributing to financial toxicity

Financial toxicity of cancer treatment is now a well-recognised problem in cancer medicine leading to patient bankruptcy and even poor survival, including in high-income countries and countries with public health care systems. Many oncologists, despite acknowledging the severity of financial toxicity as a problem, resign the responsibility of reducing the costs of cancer treatment to the govern...

Financial toxicity in survivors of childhood cancer and their siblings: A proposal to include a financial toxicity instrument in the Follow-Up 6 survey

Study team: Paul Nathan [email protected] Rena Conti [email protected] Tara Henderson [email protected] Robin Yabroff [email protected] I-Chan Huang [email protected] Elyse Park [email protected] Kevin Krull [email protected] Anne Kirchhoff [email protected] Todd Gibson [email protected] Les Robison [email protected] Greg Armstrong g...

Financial Depth – Financial Repression Linkage